Estados financieros detallados de NeoGenomics, Inc. (NEO): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
NeoGenomics, Inc. registró ingresos de $727.3M en el último ejercicio fiscal, con un CAGR de 5 años del 10.4%.
Márgenes de los últimos 12 meses: margen bruto 42.9%, margen operativo -8.6%, margen neto -6.8%.
Al precio actual de $18.94, NEO presenta beneficios negativos (P/E no significativo) y un ROE del -6.31%. La capitalización bursátil es de $487M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $244.1M | $240.3M | $276.7M | $408.8M | $444.4M | $484.3M | $509.7M | $591.6M | $660.6M | $727.3M |
| Coste de Ventas | $133.7M | $138.3M | $149.5M | $212.0M | $258.6M | $297.3M | $321.8M | $347.0M | $370.5M | $444.8M |
| Beneficio Bruto | $110.4M | $102.0M | $127.3M | $196.8M | $185.9M | $187.1M | $187.9M | $244.6M | $290.1M | $282.5M |
| I+D | $4.6M | $3.6M | $3.0M | $8.5M | $8.2M | $21.9M | $30.3M | $27.3M | $31.2M | $37.1M |
| Generales y Administrativos | $87.8M | $113.3M | $114.2M | $175.3M | $191.7M | $283.9M | $277.9M | $280.0M | $310.5M | $365.3M |
| Gastos Operativos | $95.9M | $99.1M | $117.2M | $183.8M | $199.9M | $305.8M | $345.5M | $352.3M | $382.2M | $348.6M |
| Beneficio Operativo | $2.6M | $2.9M | $10.0M | $13.0M | -$14.0M | -$118.8M | -$157.6M | -$107.7M | -$92.1M | -$66.1M |
| EBITDA | $25.4M | $26.6M | $31.8M | $37.6M | $34.9M | $46.5M | -$82.3M | -$17.6M | -$1.5M | -$38.7M |
| Gastos por Intereses | $10.0M | $5.5M | $6.2M | $3.7M | $7.0M | $8.2M | $7.6M | $6.9M | $6.6M | $3.8M |
| Beneficio Antes de Impuestos | -$7.4M | -$2.6M | $3.8M | $3.6M | -$14.1M | -$15.1M | -$159.3M | -$97.1M | -$80.7M | -$110.3M |
| Impuestos | -$1.7M | -$2.3M | $1.2M | -$4.4M | -$18.2M | -$6.7M | -$15.1M | -$9.1M | -$1.9M | -$2.2M |
| Beneficio Neto | -$6.1M | -$396000 | $2.6M | $8.0M | $4.2M | -$8.3M | -$144.2M | -$88.0M | -$78.7M | -$108.0M |
| BPA | $-0.40 | $-0.03 | $0.14 | $0.40 | $0.19 | $-0.35 | $-5.80 | $-3.50 | $-3.10 | $-4.20 |
| BPA Diluido | $-0.40 | $-0.03 | $0.14 | $0.39 | $0.19 | $-0.35 | $-5.80 | $-3.50 | $-3.10 | $-4.20 |
| Acciones en Circulación (Diluidas) | $15.5M | $15.9M | $18.3M | $20.7M | $22.4M | $24.0M | $24.8M | $25.1M | $25.3M | $25.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $187.8M | $190.2M | $186.7M | $201.7M |
| Beneficio Bruto | $80.4M | $75.7M | $80.9M | $91.9M |
| Beneficio Operativo | -$27.0M | -$11.1M | -$18.2M | -$9.8M |
| EBITDA | -$10.0M | $4.6M | -$567000 | $18.8M |
| Beneficio Neto | -$27.1M | -$9.9M | -$17.1M | $2.2M |
| BPA | $-1.05 | $-0.38 | $-0.65 | $0.10 |
| BPA Diluido | $-1.05 | $-0.38 | $-0.65 | $0.10 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $12.5M | $12.8M | $9.8M | $173.0M | $228.7M | $316.8M | $263.2M | $342.5M | $367.0M | $159.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $67.5M | $198.6M | $174.8M | $72.7M | $19.8M | 0 |
| Cuentas por Cobrar | $55.5M | $60.4M | $76.9M | $95.2M | $106.8M | $112.1M | $119.7M | $131.3M | $150.5M | $159.2M |
| Inventario | $6.3M | $7.5M | $8.7M | $14.4M | $29.5M | $23.4M | $24.3M | $24.2M | $26.7M | $28.6M |
| Activos Corrientes | $78.8M | $85.0M | $103.7M | $290.7M | $448.7M | $681.5M | $605.3M | $596.8M | $596.0M | $376.3M |
| Inmovilizado Material | $34.0M | $36.5M | $60.9M | $90.7M | $151.9M | $211.7M | $198.6M | $183.8M | $173.7M | $163.3M |
| Fondo de Comercio | $147.0M | $147.0M | $197.9M | $198.6M | $211.1M | $527.1M | $522.8M | $522.8M | $522.8M | $524.3M |
| Activos Intangibles | $77.1M | $74.2M | $140.0M | $126.6M | $120.7M | $442.3M | $408.3M | $373.1M | $339.7M | $286.5M |
| Activos Totales | $337.1M | $343.3M | $505.0M | $709.5M | $988.3M | $1.87B | $1.74B | $1.68B | $1.64B | $1.36B |
| Cuentas por Pagar | $16.8M | $10.4M | $17.8M | $19.6M | $25.0M | $17.9M | $20.5M | $20.3M | $21.6M | $23.1M |
| Deuda a Corto | $3.8M | $3.8M | $14.2M | $13.8M | $2.8M | $1.1M | 0 | 0 | $200.8M | $4.8M |
| Pasivos Corrientes | $59.9M | $35.1M | $60.9M | $63.9M | $73.2M | $87.2M | $89.9M | $96.3M | $301.2M | $88.3M |
| Deuda a Largo | $92.1M | $91.2M | $98.1M | $91.8M | $168.1M | $532.5M | $535.3M | $538.2M | $340.3M | $404.7M |
| Pasivos Totales | $150.5M | $137.8M | $184.6M | $202.1M | $294.0M | $761.5M | $742.0M | $739.7M | $735.7M | $523.3M |
| Reservas | -$52.5M | -$57.5M | -$51.3M | -$11.4M | -$7.2M | -$14.8M | -$159.1M | -$247.1M | -$325.8M | -$433.8M |
| Patrimonio Neto | $186.6M | $205.5M | $320.4M | $507.4M | $694.3M | $1.11B | $998.0M | $941.5M | $902.3M | $836.6M |
| Deuda Total | $106.2M | $105.4M | $112.3M | $132.9M | $218.2M | $612.8M | $610.9M | $611.7M | $605.3M | $472.3M |
| Deuda Neta | $93.6M | $92.6M | $102.5M | -$40.1M | -$78.0M | $97.4M | $172.9M | $196.5M | $218.5M | $312.7M |
| Capital Circulante | $18.9M | $49.9M | $42.7M | $226.8M | $375.5M | $594.3M | $515.4M | $500.5M | $294.8M | $288.0M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $164.1M | $159.6M | $146.1M | $145.5M |
| Activos Totales | $1.37B | $1.36B | $1.35B | $1.35B |
| Pasivos Totales | $536.5M | $523.3M | $517.8M | $565.6M |
| Patrimonio Neto | $838.3M | $836.6M | $828.8M | $785.7M |
| Deuda Total | $410.3M | $472.3M | $408.5M | $448.4M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$5.7M | -$846000 | $2.6M | $8.0M | $4.2M | -$8.3M | -$144.2M | -$88.0M | -$78.7M | -$108.0M |
| Amortizaciones | $23.2M | $22.6M | $21.7M | $30.3M | $35.7M | $53.4M | $69.4M | $72.6M | $72.5M | $67.8M |
| Compensación en Acciones | $5.4M | $6.4M | $7.0M | $10.0M | $10.2M | $22.5M | $24.7M | $24.6M | $33.4M | $41.3M |
| Cambio en Capital Circulante | -$21.4M | -$30.5M | $12.5M | -$32.4M | -$61.7M | -$4.6M | -$31.7M | -$25.5M | -$32.6M | -$32.1M |
| Flujo de Caja Operativo | $21.5M | $18.0M | $44.8M | $23.4M | $1.5M | -$26.7M | -$66.0M | -$2.0M | $7.0M | $5.2M |
| Inversiones (CapEx) | -$7.5M | -$13.7M | -$14.3M | -$20.0M | -$29.1M | -$64.1M | -$30.9M | -$28.8M | -$41.1M | -$27.0M |
| Adquisiciones | $1.0M | 0 | -$125.4M | $399000 | -$37.0M | -$419.4M | 0 | 0 | 0 | -$6.5M |
| Recompra de Acciones | -$55.0M | 0 | -$50.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | $13.9M | $4.3M | $30.5M | $3.3M | -$27.6M | -$90.9M | -$96.9M | -$30.7M | -$34.0M | -$21.8M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | $8.9M | $1.3M | -$8.1M | $20.0M |
| Inversiones (CapEx) | -$8.3M | -$7.9M | -$5.0M | -$8.2M |
| Flujo de Caja Libre | $570000 | -$6.5M | -$13.1M | $11.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $10.3M | 0 | $9.6M | $8.2M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -1.6% | +15.2% | +47.7% | +8.7% | +9.0% | +5.2% | +16.1% | +11.6% | +10.1% |
| Crecimiento Beneficio Neto (anual) | | +93.6% | +766.7% | +203.3% | -47.9% | -300.1% | -1628.2% | +39.0% | +10.5% | -37.2% |
| Crecimiento BPA (anual) | | +93.8% | +660.0% | +185.7% | -52.5% | -284.2% | -1557.1% | +39.7% | +11.4% | -35.5% |
| Cambio en Acciones (anual) | | +2.4% | +15.3% | +13.2% | +7.9% | +7.3% | +3.5% | +1.0% | +0.9% | +1.1% |
| Crecimiento FCF (anual) | | -68.8% | +601.1% | -89.0% | -927.4% | -228.8% | -6.6% | +68.3% | -10.9% | +36.0% |
| Margen Bruto | 45.2% | 42.4% | 46.0% | 48.1% | 41.8% | 38.6% | 36.9% | 41.3% | 43.9% | 38.8% |
| Margen Operativo | 1.1% | 1.2% | 3.6% | 3.2% | -3.1% | -24.5% | -30.9% | -18.2% | -13.9% | -9.1% |
| Margen EBITDA | 10.4% | 11.1% | 11.5% | 9.2% | 7.8% | 9.6% | -16.2% | -3.0% | -0.2% | -5.3% |
| Margen Neto | -2.5% | -0.2% | 1.0% | 2.0% | 0.9% | -1.7% | -28.3% | -14.9% | -11.9% | -14.9% |
| Margen FCF | 5.7% | 1.8% | 11.0% | 0.8% | -6.2% | -18.8% | -19.0% | -5.2% | -5.2% | -3.0% |
| Tasa Impositiva Efectiva | 22.9% | 85.1% | 31.0% | -119.6% | 129.7% | 44.6% | 9.5% | 9.4% | 2.4% | 2.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $0.90 | $0.27 | $1.66 | $0.16 | $-1.24 | $-3.79 | $-3.90 | $-1.22 | $-1.34 | $-0.85 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $15.5M | $15.9M | $18.3M | $20.1M | $21.7M | $24.0M | $24.8M | $25.1M | $25.3M | $25.6M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -6.31% |
| Rentabilidad sobre capital invertido | -5.03% |
| Rentabilidad sobre activos | -3.84% |
| Margen bruto | 42.92% |
| Margen operativo | -8.63% |
| Margen neto | -6.77% |
Salud financiera
| Deuda / Patrimonio | 0.57 |
| Ratio corriente | 3.60 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 0.53 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -21.64 | -354.40 | 87.57 | 73.40 | 280.42 | -98.05 | -1.59 | -4.62 | -5.32 | -2.80 |
| P/VC | 0.71 | 0.68 | 0.72 | 1.16 | 1.68 | 0.74 | 0.23 | 0.43 | 0.46 | 0.36 |
| P/V | 0.54 | 0.59 | 0.83 | 1.44 | 2.63 | 1.69 | 0.45 | 0.69 | 0.63 | 0.41 |
| Margen Bruto | 45.2% | 42.4% | 46.0% | 48.1% | 41.8% | 38.6% | 36.9% | 41.3% | 43.9% | 38.8% |
| Margen Operativo | 1.1% | 1.2% | 3.6% | 3.2% | -3.1% | -24.5% | -30.9% | -18.2% | -13.9% | -9.1% |
| Margen Neto | -2.5% | -0.2% | 1.0% | 2.0% | 0.9% | -1.7% | -28.3% | -14.9% | -11.9% | -14.9% |